Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03TJN
|
||||
Former ID |
DIB016732
|
||||
Drug Name |
KOS-1803
|
||||
Synonyms |
Isoxazole-fludelone; SK-10105; Third generation epothilone (cancer), Bristol-Myers Squibb; Third generation epothilone (cancer),Kosan/Roche; 9,10-didehydro-26-trifluoro-isoazole-epothilone D
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Preclinical | [548297] | ||
Company |
Memorial Sloan-Kettering Cancer Center
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C\1=C(\C/C=C/[C@@H]([C@@H]([C@H](C(=O)C([C@H](CC(=O)O[C<br />@@H](C1)/C(=C/c1cc(on1)C)/C)O)(C)C)C)O)C)/C(F)(F)F
|
||||
Target and Pathway | |||||
Target(s) | Tubulin beta | Target Info | Inhibitor | [543674] | |
PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
Huntington disease | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.